Literature DB >> 22643076

Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.

Ran Liu1, Hui Yuan, Fang Yuan, Shao-Hua Yang.   

Abstract

Neuroprotection to attenuate or block the ischemic cascade and salvage neuronal damage has been extensively explored for the treatment of ischemic stroke. In the last two decades, neuroprotective strategy has been evolving from targeting a signal pathway in neurons to protecting all neurovascular components and improving cell-cell and cell-extracellular matrix interaction that ultimately benefits the brain recovery after ischemic stroke. The progression from potentially reversible to irreversible injury in the ischemic penumbra has provided the opportunity to develop therapies to attenuate the ischemic stroke damage. Thus, the ischemic penumbra has been the main target for the current neuroprotective intervention. However, despite our increasing knowledge of the physiologic, mechanistic, and imaging characterizations of the ischemic penumbra, no effective neuroprotective therapy has been found so far for the treatment of ischemic stroke. The current acute neuroprotective approach focusing on the damaging mechanisms at the ischemic penumbra is greatly limited by the rapid evolution of the deleterious cascades in the ischemic penumbra. Neuroprotective intervention attempts to promote endogenous repairing in the transition zone of the penumbra for the therapeutic purposes may overcome the unrealistic therapeutic windows under the current neuroprotective strategy. In addition, increasing evidence has indicated ischemic stroke could induce long-lasing cellular and hemodynamic changes beyond the ischemic territory. It is unclear whether and how the global responses induced by the ischemic cascade contribute to the progression of cognitive impairment after ischemic stroke. The prolonged pathophysiological cascades induced by ischemic stroke beyond the ischemic penumbra might provide novel therapeutic opportunities for the neuroprotective intervention, which could prevent or slow down the progression of vascular dementia after ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22643076     DOI: 10.1179/1743132812Y.0000000020

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  25 in total

1.  Scheme of Ischaemia-triggered Agents during Brain Infarct Evolution in a Rat Model of Permanent Focal Ischaemia.

Authors:  Petra Bonova; Viera Danielisova; Miroslava Nemethova; Milina Matiasova; Martin Bona; Miroslav Gottlieb
Journal:  J Mol Neurosci       Date:  2015-05-14       Impact factor: 3.444

2.  Monitoring Acute Stroke Progression: Multi-Parametric OCT Imaging of Cortical Perfusion, Flow, and Tissue Scattering in a Mouse Model of Permanent Focal Ischemia.

Authors:  Woo June Choi; Yuandong Li; Ruikang K Wang
Journal:  IEEE Trans Med Imaging       Date:  2019-01-31       Impact factor: 10.048

3.  Time-course investigation of blood-brain barrier permeability and tight junction protein changes in a rat model of permanent focal ischemia.

Authors:  Peng Liu; Rui Zhang; Danyang Liu; Jinling Wang; Chunling Yuan; Xuemei Zhao; Yinjie Li; Xuefei Ji; Tianyan Chi; Libo Zou
Journal:  J Physiol Sci       Date:  2017-01-11       Impact factor: 2.781

4.  Beneficial Effects of Delayed P7C3-A20 Treatment After Transient MCAO in Rats.

Authors:  Zachary B Loris; Justin R Hynton; Andrew A Pieper; W Dalton Dietrich
Journal:  Transl Stroke Res       Date:  2017-08-25       Impact factor: 6.829

5.  Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia.

Authors:  Xiao Zhang; Ming Shi; Ruidong Ye; Wei Wang; Xuedong Liu; Guangyun Zhang; Junliang Han; Yunxia Zhang; Bing Wang; Jun Zhao; Juan Hui; Lize Xiong; Gang Zhao
Journal:  Neurochem Res       Date:  2014-05-03       Impact factor: 3.996

6.  Transient focal cerebral ischemia induces long-term cerebral vasculature dysfunction in a rodent experimental stroke model.

Authors:  Ali Winters; Jessica C Taylor; Ming Ren; Rong Ma; Ran Liu; Shao-Hua Yang
Journal:  Transl Stroke Res       Date:  2012-03-06       Impact factor: 6.829

7.  Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.

Authors:  Irène R Chassagnon; Claudia A McCarthy; Yanni K-Y Chin; Sandy S Pineda; Angelo Keramidas; Mehdi Mobli; Vi Pham; T Michael De Silva; Joseph W Lynch; Robert E Widdop; Lachlan D Rash; Glenn F King
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

8.  Knockdown of microRNA-17-5p Enhances the Neuroprotective Effect of Act A/Smads Signal Loop After Ischemic Injury.

Authors:  Jiao-Qi Wang; Yue Dong; Si-Jia Li; Cheng-Liang Pan; Hong-Yu Liu; Yu-Kai Wang; Lei Xu; Jia-Hui Yang; Yun-Xia Cui; Jin-Ting He; Jing Mang; Zhong-Xin Xu
Journal:  Neurochem Res       Date:  2019-05-15       Impact factor: 3.996

9.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

10.  5-Lipoxygenase inhibitor zileuton inhibits neuronal apoptosis following focal cerebral ischemia.

Authors:  Song-sheng Shi; Wei-zhong Yang; Xian-kun Tu; Chun-hua Wang; Chen-mei Chen; Yan Chen
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.